Bibliographic Info
GuidelineWHO guidelines for malaria, 3 June 2022.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Low
Reactive drug administration for reducing malaria transmission: In areas approaching elimination or post-elimination settings preventing re-establishment of transmission, antimalarial medicine can be given as chemoprevention to all people residing with or near a confirmed malaria case and all people who share the same risk of infection (e.g. co-travellers and co-workers) to prevent or reduce malaria transmission.
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO guidelines for malaria, 25 November 2022.
Year2022
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 16 October 2023.
Year2023
InstitutionWorld Health Organization
Guideline
WHO Guidelines for malaria, 14 March 2023
Year2023
InstitutionWHO
Guideline
WHO guidelines for malaria, 30 November 2024.
Year2024
InstitutionWHO
Guideline
WHO guidelines for malaria, 13 August 2025
Year2025
InstitutionWorld Health Organization